Creative Enzymes

Executive Summary

Creative Enzymes, founded in 2005 and headquartered in Shirley, New York, is a private biotechnology company offering a broad portfolio of enzymes, probiotics, and extracts for industrial and research applications. Serving diverse sectors including diagnostics, food and beverage, health and nutrition, and environmental waste management, the company provides both off-the-shelf products and custom services such as enzyme discovery, engineering, and large-scale production. With over two decades of operation, Creative Enzymes has established itself as a reliable partner for clients requiring specialized enzymatic solutions, leveraging its technical expertise to address complex biological challenges across multiple industries. The company's longevity and diversified customer base underscore its operational stability, though its private status limits visibility into financial performance or growth trajectory. Key strengths include a wide product range, custom service capabilities, and exposure to high-growth end markets like diagnostics and environmental remediation. However, competition from larger enzyme providers and limited public information temper its investment appeal. Given its established presence and niche positioning, Creative Enzymes represents a moderate conviction opportunity, with potential upside tied to expansion in applied enzyme markets and strategic partnerships.

Upcoming Catalysts (preview)

• Q4 2026Launch of new diagnostic enzyme product line70% success
• Q2 2027Strategic partnership with major food & beverage company60% success
• Q1 2027Expansion into custom enzyme engineering for environmental waste management50% success